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Abstract
Background: The serotonin (5-HT) 2A and 2C receptors (5-HT2AR and 5-HT2CR) are involved in a wide range of
physiological and behavioral processes in the mammalian central and peripheral nervous systems. These receptors
share a high degree of homology, have overlapping pharmacological profiles, and utilize many of the same and
richly diverse second messenger signaling systems. We have developed quantitative assays for cells stably
expressing these two receptors involving minimal cell sample manipulations that dramatically improve parallel
assessments of two signaling responses: intracellular calcium (Cai
++) changes and activation (phosphorylation) of
downstream kinases. Such profiles are needed to begin to understand the simultaneous contributions from the
multiplicity of signaling cascades likely to be initiated by serotonergic ligands.
Results: We optimized the Cai
++ assay for stable cell lines expressing either 5-HT2AR or 5-HT2CR (including dye use
and measurement parameters; cell density and serum requirements). We adapted a quantitative 96-well plate
immunoassay for pERK in the same cell lines. Similar cell density optima and time courses were observed for 5-
HT2AR- and 5-HT2CR-expressing cells in generating both types of signaling. Both cell lines also require serum-free
preincubation for maximal agonist responses in the pERK assay. However, 5-HT2AR-expressing cells showed
significant release of Cai
++ in response to 5-HT stimulation even when preincubated in serum-replete medium,
while the response was completely eliminated by serum in 5-HT2CR-expressing cells. Response to another
serotonergic ligand (DOI) was eliminated by serum-replete preincubation in both cells lines.
Conclusions: These data expand our knowledge of differences in ligand-stimulated signaling cascades between 5-
HT2AR and 5-HT2CR. Our parallel assays can be applied to other cell and receptor systems for monitoring and
dissecting concurrent signaling responses.
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Background
The serotonin (5-HT) 2A and 2C receptors (5-HT2AR
and 5-HT2cR) are seven-transmembrane, G protein-
coupled receptors (GPCRs) that are expressed in numer-
ous brain regions. The 5-HT2CR protein is expressed
predominantly in the central nervous system while the
5-HT2AR is also prominent in peripheral tissues, such as
platelets and smooth muscle cells of the gut and vascu-
lature [1]. Both receptors are involved in a wide range
of physiological (e.g., temperature regulation, feeding)
and psychological processes in mammals [2] and are
implicated in psychological disorders (e.g., addiction,
anxiety, depression, and learning and memory) [3-5].
These receptors share a high degree of homology, have
overlapping pharmacological profiles, and utilize many
of the same and richly diverse second messenger signal-
ing systems. The most commonly studied downstream
signaling pathway of the 5-HT2ARa n d5 - H T 2CRi st h e
* Correspondence: cswatson@utmb.edu
1Center for Addiction Research, University of Texas Medical Branch,
Galveston TX 77555, USA
Full list of author information is available at the end of the article
Seitz et al. BMC Neuroscience 2012, 13:25
http://www.biomedcentral.com/1471-2202/13/25
© 2012 Seitz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.activation of phospholipase Cb (PLCb) via Gaq/11 pro-
teins and the production of inositol-1,4,5-trisphosphate
(IP3) and diacylglycerol (DAG), leading to increased Ca
+
+ release from intracellular stores [6,7]. However, both
receptors also activate phospholipase A2 (PLA2), possibly
through Gi/o or G12/13, resulting in increased arachido-
nic acid (AA) release and have also been shown to acti-
vate phospholipase D [8,9] independent of PLC
activation. The degree to which these downstream sig-
naling pathways are recruited varies between the recep-
tors, both in terms of the level of constitutive (agonist-
independent) activation of each of the pathways [10]
(particularly for the 5-HT2CR, where constitutive activity
is highly dependent on the degree of editing) as well as
ligand-directed signaling of agonists for the 5-HT2AR
and 5-HT2CR [11]. These differences in signal activation
m a yb eak e yf e a t u r ed i s t i n g u i s h i n gt h ef u n c t i o n a l
effects of these two receptors. Thus, an appreciation of
the full spectrum of downstream signal activation is cri-
tical when elucidating the functional actions of these
receptors as well as in screening and evaluation of novel
ligands for these receptors.
Parallel assays to measure simultaneous changes in IP3
and AA levels have been used to great advantage in
deciphering differences in selective ligand-directed sig-
naling [11], inverse agonism [12], desensitization [13,14],
coupling specificity [15] and constitutive activity [16]
between the 5-HT2ARa n d5 - H T 2cR. However, addi-
tional rapid and quantitative assays to distinguish
among further cellular responses in intact cells would
broaden our appreciation of the multiplicity of signaling
cascades likely to be initiated by serotonergic ligands. In
t h ec o u r s eo fo u rs t u d i e st od i s c o v e rn o v e ll i g a n d sf o r
the 5-HT2ARa n d5 - H T 2CR [17], we have developed
quantitative live cell assays in parallel plates that involve
minimal cell sample manipulations and improve mea-
surements of signals leading to functional activity for
cells expressing these two receptors. These assays mea-
sure two types of signaling evoked by ligand activation,
changes in intracellular calcium (Cai
++) and phosphory-
lation changes in downstream kinases, in very similar
cell preparations.
The assay to measure Cai
++ levels utilizes detection of
increased fluorescence in the presence of ionized cal-
cium by the fluorescent dye Calcium 4 (Molecular
Devices, Sunnyvale, CA) and is performed in live,
attached cells, typically in 96-well plates [18]. Changes
in Cai
++ have long been recognized as critical to cell
function, and techniques for measuring such changes
have been rapidly evolving since the initial introduction
of intracellular calcium-sensitive fluorescent dyes. We
also developed an in situ immunoassay to detect activa-
tion of one class of the downstream mitogen-activated
protein kinases (MAPKs), the extracellular-regulated
kinases (ERK1 and ERK2), to measure an additional sig-
naling event resulting from ligand binding. Phosphoryla-
tion of ERK is an example of an important integrator of
upstream signaling eventsf o rm a n yG P C R sa sw e l la s
other cellular receptors [19-21], including the 5-HT2AR
[22-27] and the 5-HT2CR [28,29]. At this pathway inter-
section many upstream signals are summed to subse-
quently coordinate actions leading to important cellular
functions, such as cell survival/apoptosis [30], growth
regulation [31,32] and differentiation [33]. Recently, acti-
vation of ERK was found to be inversely correlated with
t h ed e g r e eo fR N Ae d i t i n go ft h e5 - H T 2CR; stimulation
of the non-edited (as used in our studies) and partially
edited isoforms caused greater levels of ERK activation
than occurred with the fully edited version [34,35].
This assay to quantify the phosphorylated protein
(pERK) uses phospho-specific antibodies and also is per-
formed on attached cells fixed immediately following
ligand treatment in 96-well plates [36,37]. ERK1/2 acti-
vation following 5-HT2R stimulation [28,34,38] has pre-
viously been demonstrated by measuring pERK with
traditional methods, primarily densitometry of immuno-
blots. However, the plate immunoassay for pERK is a
much more sensitive assay [37] and the 96-well format
allows for far greater flexibility in assay design than tra-
ditional immunoblots. Many simultaneous experimental
perturbations can be performed in the same cell pre-
paration due to the rapid processing of high numbers of
samples with these assays [36,37]. The assay also pro-
vides in situ detection of ERK activation as opposed to
ELISAs and immunoblots that are performed on cell
homogenates.
We developed these assays to compare the signaling
effects resulting from stimulation by different seroto-
nergic ligands in Chinese hamster ovary (CHO-K1) cell
lines expressing either human (h)5-HT2ARo rh 5 -
HT2CR. These lines were developed by Berg and
Clarke [39] and extensive data have been accumulated
using the same lines in several laboratories
[11,13-15,17,28,34]. However, it is necessary to opti-
mize each assay for cell type and receptor system
because access to signaling response compartments is
different in cells of different tissues and lineages. In
addition, technical aspects of measuring antigens (such
as antibody concentrations and incubation times) vary
for each protein. Moreover, values for these optimized
parameters offer windows into the biological behavior
of cells expressing different receptor subtypes. For
example, the effects of cell crowding (density) on the
downregulation of membrane receptors were demon-
strated with this approach [40] as were the influences
of culturing in serum (which itself contains many
ligands). The power of the assays developed herein is
the ability to rapidly determine multiple and subtle
Seitz et al. BMC Neuroscience 2012, 13:25
http://www.biomedcentral.com/1471-2202/13/25
Page 2 of 14effects (potency, efficacy, second messenger activation)
of various ligands with minimal cell disruption or com-
parison artifacts to yield important information con-
cerning differences in signaling pathways triggered by
activation in the 5-HT2AR- and the 5-HT2CR-CHO
cells. Thus, interactions of second messenger systems
with converging downstream enzymatic endpoints can
be investigated.
Methods
Cell lines and cell culture
5-HT2AR-CHO and 5-HT2CR-CHO cells were a gener-
ous gift of K. Berg and W. Clarke (University of Texas
Health Science Center, San Antonio). The FA4 line was
transfected with h5-HT2AR( 5 - H T 2AR-CHO cells) and
the 1C19 line with unedited h5-HT2CR( 5 - H T 2CR-CHO
cells) in the p198-DHFR-Hygro vector containing a
hygromycin resistance gene [39]. Reverse transcription
of RNA followed by quantitative real time PCR assay for
both transcripts confirmed that FA4 cells expressed high
amounts of 5-HT2AR and no 5-HT2CRm R N A ,t h a t
1C19 cells expressed high amounts of 5-HT2CRa n dn o
5-HT2AR mRNA, and that the parental cell line did not
express detectable amounts of either mRNA (data not
shown). Our recent data confirmed the lack of 5-HT2CR
protein in FA4 cells and the lack of 5-HT2ARp r o t e i ni n
1C19 cells [41]. Receptor protein expression in both the
FA4 and 1C19 cells has been assessed at 200 fmol/mg
protein which approximates physiological levels in brain
[39]. Cells were grown at 37°C, 5% CO2 and 85% relative
humidity in GlutaMax™-MEM (Invitrogen, Carlsbad
CA), 5% fetal bovine serum (Atlanta Biologicals, Atlanta
GA), 100 μg/ml hygromycin (FA4 and 1C19, Mediatech,
Manassas VA) or penicillin/streptomycin (parental cells,
Invitrogen), and were passaged when they reached 80%
confluence.
Intracellular calcium assay
Changes in Cai
++ levels were determined using the cal-
cium-sensitive dye Calcium 4 (FLIPR No-wash kit,
M o l e c u l a rD e v i c e s ,S u n n y v a l eC A ,p a r t# R 8 1 4 2 ) .I no u r
hands, the Molecular Devices kit produced results with
reasonable signal intensity and reproducibility compared
to other commercially available reagents (e.g., Fluo-3
and Fluo-4) without the necessity of dye removal or
washing prior to measurements (data not shown). In
addition to convenience, the lower number of manipula-
tions required by this kit allowed for more rapid collec-
tion of data and decreased the likelihood of cell
disturbance or loss.
Cells were plated in serum-replete medium at indi-
cated densities in black-sided, clear bottom 96-well tis-
sue culture plates. Care was taken to ensure even
plating of cells, including frequent agitation or
trituration of cells in the source reservoir. When plating
v o l u m ew a sl e s st h a n1 5 0μl, cells were less evenly dis-
tributed (visual observation; data not quantified), so we
used 150 to 200 μl .C e l l sw e r ea d d e dv e r ys l o w l yt ot h e
wells to minimize clustering around the edges. Placing
the plate on a rotary shaker at low speed for several
minutes following plating also helped to distribute cells
evenly.
Except where indicated, cells were fed ~24 hrs later
with serum-free medium. Following overnight incuba-
tion, medium was removed and replaced with 40 μlo f
fresh serum-free medium plus 40 μlo fC a l c i u m4d y e
solution supplemented with 2.5 mM water soluble pro-
benicid (Invitrogen) to inhibit extracellular transport of
the dye. Plates were returned to the 37°C incubator for
30-60 min then incubated for an additional 30-60 min
at room temperature (RT) in the dark. Sixty-min incu-
bations yielded higher levels of dye loading and higher
relative fluorescence units (RFU) than 30-min incuba-
tions but did not appear to alter the final magnitude of
the stimulations when expressed as percent baseline
(data not shown).
Fluorescence (lex = 485 nm, lem = 525 nm) was mea-
sured with a FlexStation3 (Molecular Devices). We used
a larger number of measurements per well (eight),
rather than the default value (six), and high detector
sensitivity. A baseline was established for each well dur-
ing the initial segment of each run. Addition of vehicle
(Hank’s balanced saline solution (HBSS), without CaCl2
or MgCl2) or 5x concentrated test substance occurred at
17 sec. The manufacturer suggests using no greater dilu-
tion than 5-fold because of issues with the rate of diffu-
sion. We found that adding test solutions at faster
speeds (up to speed 6 = 94 μl/sec) and using the tritura-
tion function (40 μl, 1-3 times) assisted rapid mixing
and resulted in more reproducible data (data not
shown). The CHO cells remained attached under these
conditions; if using other cells lines, attachment should
be monitored and reagent addition conditions modified
as necessary.
Following addition of test reagent, fluorescence was
recorded every 1.7 sec for 90-120 sec. For both 5-
HT2ARa n d5 - H T 2CR, the peak Cai
++ response to ago-
nists occurred 10 to 20 sec following stimulation. Maxi-
mum peak height was determined by the FlexStation
software (SoftMax Pro 5.2) for each well. When testing
inhibition by antagonists, 5x concentrated antagonist
was added as above and the recording time shortened to
60 sec. This first round of measurements allowed us to
measure any inherent agonist activity and also provided
a 15 min antagonist preincubation period. Then vehicle
or 5x concentrated agonist solution was added and a
second round of measurements recorded inhibition of
the agonist response.
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++ measurements were performed following both
overnight (16-20-hr) and 48-hr incubations. The small
difference in the magnitude of the fluorescent response
was primarily due to increased cell numbers following
the longer growth period and suggested that both time
points were equally effective. Pre-coating of well sur-
faces with poly-D-lysine is a common method to
improve attachment of cells during manipulations. We
found no difference in the number of cells or in the
fluorescent response between wells with and without 10
μg/ml poly-D-lysine pre-coating (data not shown), and
consequently, wells were not coated with poly-D-lysine.
Plate immunoassay for pERK
We adapted a previously developed plate immunoassay
[36,37,42] to measure levels of pERK following receptor
stimulation. Cells were plated at the densities indicated,
grown for 24 hr in serum-replete medium then shifted
overnight to serum-free medium; similar to results for
the Cai
++ assay, coating wells with poly-D-lysine had no
effect on plate immunoassay results (data not shown)
and therefore was not utilized. The day of the experi-
ment, cells were fed with 80 μlo fs e r u m - f r e em e d i u m
and returned to the incubator for 1-2 hrs, as adding
medium alone caused a measurable activation of ERK
that subsided by 1 hr (data not shown). Ligands were
added as 20 μl of a 5x stock concentration for the indi-
cated time. Reactions were stopped by the addition of
100 μl phosphate buffered saline (PBS; pH 7.4) with 4%
paraformaldehyde (PFA; resulting in a final concentra-
tion of 2% PFA). Optimal fixation time for CHO cells in
this assay was 45 min at RT (data not shown). Cells
were then permeabilized with ice-cold methanol to
ensure antibody access to intracellular antigens, washed
with PBS, and blocked for 45 min at RT with 0.1% fish
gelatin (Sigma). Cells then were incubated with 1:500
dilution of mouse monoclonal anti-pERK (p44/42, Cell
Signaling, #9106) overnight at 4°C with gentle shaking.
Background was determined in a group of eight wells
incubated with no primary antibody. After washing with
PBS, biotin-conjugated secondary antibody (Vector Labs,
# BA-9200, 1:500 dilution in blocking solution) was
added and incubated for 1 hr at RT. Following washing,
alkaline phosphatase (AP) complexed with avidin (Vec-
tor Labs, #AK5000) was prepared according to the man-
ufacturer’s directions, added to the wells and incubated
for 1 hr at RT. After washing, 50 μlt h eA Ps u b s t r a t e
para-nitrophenyl-phosphate (pNpp; Vector Labs, #SK-
5900; 20 drops/10 ml) with levamisole (an inhibitor of
endogenous phosphatases, Vector Labs, #SP-5000; two
drops/10 ml) freshly prepared in 100 mM sodium bicar-
bonate was added and the plate was incubated at 37°C
for 30 min. The absorbance of the yellow product para-
nitrophenol (pNp) was measured at 405 nm (A405).
Crystal violet staining
Data were normalized to total cell mass as measured by
crystal violet staining, a value proportional to cell mass
that can be used as an estimate of cell number in each
well [43]. Wells were rinsed with water, air dried and 50
μl of crystal violet solution (0.1% in water) was added
for 30 min at RT, and the wells were rinsed again. Cell-
adsorbed dye was extracted by the addition of 50 μlo f
10% acetic acid (30 min, RT) and absorbance read at
590 nm. Levels of pERK per well were expressed as
A405/A590.
Data analysis
Replicates of 3-8 wells were utilized for Cai
++ assays and
replicates of 5-8 wells for pERK assays. The number of
independent experiments performed is indicted in indi-
vidual figure legends. Differences between groups were
determined by one-way ANOVA, followed by Bonfer-
roni post hoc test; p values < 0.05 were considered
significant.
Reagents and ligands
5-HT (Acros Organics, NJ); 1-[2, 5-dimethoxy-4-iodo-
phenyl]-2 aminopropane (DOI), crystal violet and poly-
D-lysine (Sigma, St. Louis, MO); SB216641 and SB
242084 (Tocris Bioscience, Ellisville MO); racemic
M100907 (synthesized [17] in the laboratory of Scott
Gilbertson, University of Houston, Houston, TX)
Results
Intracellular calcium assay
Cell density
Changes in Cai
++ release in response to a fixed concen-
tration (1 μM) of 5-HT were measured at increasing cell
densities in 5-HT2AR-CHO (Figure 1, A-C) and 5-
HT2CR-CHO cells (Figure 1, D-F). Figure 1A/1D plots
peak fluorescence; as expected, this parameter increased
significantly (each bar is compared to the previous bar)
as a function of plating density. Data in Figure 1B/1E
were normalized to cell mass by the crystal violet assay.
Data in Figure 1C/1F were expressed as a percentage of
baseline fluorescence determined for each individual
well. This representation also is dependent on cell num-
ber, but depends on other factors as well, such as dye
loading; therefore, one would not necessarily expect a
perfectly linear relationship.
Plating at low densities (2000-8000 cells/well) resulted
in low RFUs, and the response was not strictly propor-
tional when normalized to cell number (Figure 1B/1E).
At these plating densities, there were noticeable spaces
between cells at the time of assay. This increased the
likelihood that one or more of the detection measure-
ments occurred at an area without cells, thus decreasing
mean signal intensity and increasing relative error. The
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to 64,000 cells per well for 5-HT2AR-CHO cells and
over 8000 to 32,000 cells per well for 5-HT2CR-CHO
cells (no significant differences compared to previous
bar). Cells plated at 64,000 cells/well sometimes began
to detach following overnight incubation, an effect more
pronounced in the 5-HT2CR-CHO cells. Consequently,
normalized response levels did not increase in 5-
HT2AR-CHO cells (Figure 1B and 1C) or began to
decrease in 5-HT2CR-CHO cells (Figure 1E and 1F)
when cells were plated at 64,000 cells/well. This effect
was evident when data were normalized in either
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Figure 1 Effect of plating density on Cai
++ response to ligand stimulation of 5-HT2AR-CHO (A-C) and 5-HT2CR-CHO cells (D-F). Cells were
plated at indicated densities, loaded with Calcium 4 and stimulated with 1 μM 5-HT. (A, B) Raw peak fluorescence, expressed as relative
fluorescent units (RFUs). (C, D) Cell number was estimated by staining with crystal violet and fluorescence normalized to A590.( E, F) Fluorescence
was normalized to baseline fluorescence of each individual well. Graph is representative of three independent experiments. n = 7-8; * p < 0.05,
** p < 0.01, *** p < 0.001 vs. previous bar.
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32,000 cells/well for subsequent studies with both 5-
HT2AR- and 5-HT2CR-CHO cells.
As mentioned above, expressing the data as a percen-
tage of baseline fluorescence (Figure 1C/1F) achieved a
less precise normalization to cell number than utilizing
the crystal violet method (Figure 1B/1E) for different
cell densities. However, the percentage of baseline calcu-
lation can be performed directly with the FlexStation
software (SoftMax Pro 5.2) without additional manipula-
tions. Therefore, this method was utilized when cell
plating density was constant within a given experiment.
Protocol adaptations for our cell systems
The protocol from the Calcium 4 and FlexStation man-
ufacturer recommended adding dye solution directly to
serum-containing growth medium. We had several con-
cerns about this protocol: 1) serum contains multiple
growth-promoting agents, ligands and binding proteins
for small molecules. The effects of these factors can
alter responses (stimulatory or inhibitory) and compli-
cate interpretation of the data; 2) after overnight (or
longer) incubations, differential evaporation might affect
the amount of growth medium remaining and this effect
might vary among wells; as a result, adding fixed
volumes of dye reagent and test solutions to the med-
ium could result in variable and imprecise final concen-
trations. Therefore, we explored a variety of
modifications to assess the impact of these problems
and to achieve a consistent and reproducible protocol.
The release of Cai
++ evoked by 5-HT or the 5-HT2 ago-
nist DOI was measured in 5-HT2AR-CHO cells to deter-
mine the effects of serum present during overnight
preincubation and during Cai
++ measurements (Figure 2).
“Serum Starved” cells were preincubated overnight in
serum-free medium, while “No Serum during Dye Load-
ing” cells were preincubated overnight in serum-replete
medium. Dye was loaded for these two groups by remov-
ing preincubation medium, adding equal volumes (80 μl)
of fresh serum-free medium and dye then incubating as
described in Methods. “Serum Replete” cells were preincu-
bated overnight in medium containing serum; preincuba-
tion medium was not removed; 80 μlo fd y ew a sa d d e d
directly to 80 μl serum-replete growth medium as per the
manufacturer’s instructions. Data in Figure 2 were normal-
ized to crystal violet (A590) to account for the different cell
numbers resulting from the different growth conditions.
Addition of 1 μM of either 5-HT or DOI resulted in easily
measurable fluorescence in both “Serum Starved” and “No
Serum during Dye Loading” groups. When dye was added
into the existing growth medium ("Serum Replete” cells),
the response to 5-HT was dramatically reduced and the
response to DOI was completely eliminated. In addition,
vehicle (saline) alone produced a readily detectable
response (18.6 +/- 2.6% compared to baseline) in the
“Serum Replete” cells. The analogous experiment was not
performed on 5-HT2CR-CHO cells because of the even
more rigid requirement for serum-free preincubation in
these cells: without serum starvation, there was no
response to either 5-HT or DOI (see Figure 3C and 3D,
below). Our purpose was to compare the protocol sug-
gested by the manufacturer to protocols that utilized pre-
incubation in serum-free conditions. The altered protocols
were a clear improvement.
Therefore, we adopted a protocol that involved over-
night preincubation in serum-free medium and replace-
ment with fresh serum-free medium and dye solution
prior to testing. Removal of the growth medium also
enabled us to decrease the final volume in each well (80
μl as opposed to 160 μl) in subsequent experiments, thus
doubling the number of samples that can be measured
per bottle of dye and decreasing the expense for this
costly reagent. This lower volume of reagent also allowed
sufficient space in the wells for addition of the two
reagents (antagonist and agonist) required in experiments
measuring inhibition of Cai
++ release by antagonists.
Effect of serum starvation
The concentration dependence of agonist-stimulated Cai
++ release also was compared in cells preincubated over-
night in serum-replete vs. serum-free media. Figure 3
shows Cai
++ responses to varying concentrations of 5-
HT (left panels) and DOI (right panels), all expressed as
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starved cells. Figure 3A, B show 5-HT2AR-CHO cells
and Figure 3C, D show 5-HT2CR-CHO cells. Cells were
incubated overnight in serum-containing (closed circles)
or serum-free medium (open circles). In 5-HT2AR-CHO
cells (Figure 3A), the 5-HT concentration response
curve was shifted rightward by serum pretreatment,
implying a decrease in ligand potency or cell sensitivity.
However, the maximum response level was not signifi-
cantly altered. In contrast, the 5-HT response in 5-
HT2CR-CHO cells decreased in both potency/sensitivity
and in maximum level of response (Figure 3C) when
cells were pretreated with serum-replete medium. For
both cell types, the maximal response to DOI was lower
than the maximal response to 5-HT. The response to
DOI was virtually eliminated with serum preincubation.
Specificity of receptor responses
To confirm that the responses measured were the result
of stimulation of the 5-HT2ARo r5 - H T 2CRi nt h e
respective cells lines, we measured inhibition of 5-HT-
stimulated Cai
++ release by selective antagonists. Figure
4A demonstrates that the Cai
++ response was completely
inhibited in 5-HT2AR-CHO cells by 15 min pretreat-
ment with the selective 5-HT2AR antagonist M100907
and in 5-HT2CR-CHO cells by pretreatment with the
selective 5-HT2CR antagonist SB242084. In addition,
CHO-K1 cells have been reported to express 5-HT1BR.
To ascertain whether the presence 5-HT1BRi nt h ep a r -
ental line contributed to response of the 5-HT2AR-CHO
and 5-HT2CR-CHO cells, we used two approaches. Fig-
ure 4B (inset) shows no Cai
++ release by the parental
CHO-K1 cells to any concentration of 5-HT. (Note the
expanded y-axis.) In a few experiments, these cells
exhibited a small (< 5% above baseline) Cai
++ release
above 10
-6 M 5-HT but this was not a consistent find-
ing. There was no detectable response to 5-HT in the
pERK assay (data not shown). Figure 4B also depicts a
Cai
++ concentration response of 5-HT2CR-CHO cells to
5 - H Ta l o n ea n di nt h ep r e s e n c eo f1 0
-6 Mo ft h e
[5-HT] (log M)
veh  -10  -9  -8  -7  -6  -5
0
20
40
60
80
100
[DOI] (log M)
veh  -10  -9  -8  -7  -6  -5
A
g
o
n
i
s
t
 
S
t
i
m
u
l
a
t
e
d
 
C
a
i
+
+
 
R
e
l
e
a
s
e
(
%
 
R
e
s
p
o
n
s
e
 
t
o
 
1
 
µ
µ
µ
µ
M
 
5
-
H
T
)
0
20
40
60
80
100
120
A. 5-HT2AR 
D. 5-HT2CR
Serum replete
Serum starved
B. 5-HT2AR
***
***
***
*** *
*** *** ***
***
***
C. 5-HT2CR
*
*** ***
*** *** ***
*
***
*** ***
*** ***
Figure 3 Concentration and serum preincubation dependence of Cai
++ release by 5-HT and DOI in CHO cells expressing 5-HT2AR (A, B)
or 5-HT2CR (C, D). Cells plated at 16,000 cells/well in 96-well plates for 24 hrs were either preincubated overnight in serum-free (open circles) or
in serum-replete (closed circles) medium and loaded with Calcium 4. Peak height following stimulation was recorded for each well and
normalized to the maximal response to 5-HT. n = 5-6; * p < 0.05, *** p < 0.001 vs. respective serum preincubation.
Seitz et al. BMC Neuroscience 2012, 13:25
http://www.biomedcentral.com/1471-2202/13/25
Page 7 of 14selective 5-HT1BR antagonist SB216641. There is no sig-
nificant difference in the response at any concentration
of 5-HT. Consequently, 5-HT1BR does not measurably
contribute to the detected responses and SB216641 was
not routinely included in subsequent assays.
Agonist concentration
Data in Figure 3 were used to determine EC50sf o r
responses of the 5-HT2AR- and 5-HT2CR-CHO cells to
5 - H Ta n dD O Ia n da r es u m m a r i z e di nT a b l e1 .D O Ii s
usually considered a preferential 5-HT2AR agonist. How-
ever, DOI previously has been shown to significantly
activate the 5-HT2CR in this cell line [11,28,34].
Responses to the preferential 5-HT2CR agonist MK212
were also measured following serum-replete and serum-
free preincubation. There was no detectable Cai
++
release in 5-HT2AR-CHO cells at any tested
concentration up to 10
-4 M. Response to MK212 in
serum-starved 5-HT2CR-CHO cells was of low magni-
tude (data not shown) and was greatly decreased when
cells were preincubated in serum-replete medium.
Plate immunoassay for pERK
Time course of ERK activation
We measured the activation of ERK in 5-HT2AR- and 5-
HT2CR-CHO cells at varying times. Cells (plated at
16,000 cells/well) were serum-starved overnight before
treatment with 1 μM 5-HT for the indicated times (Fig-
ure 5). The time course of ERK activation was similar,
though not identical, for these two cell lines. There was
a distinct peak at 5 min followed by a return to baseline
or near baseline levels of phosphorylation at 10 min. A
second lower level increase was then sustained from 20
min to beyond 60 min, and was similar for both 5-
HT2AR- and 5-HT2CR-CHO cells. Such a pattern is typi-
cal for ligand-stimulated ERK responses. The rapid post-
activation dephosphorylation seen for the 5-HT2CR-
[Antagonist] (log M)
 Veh  -10  -9  -8  -7  -6  -5  -4
R
e
l
a
t
i
v
e
 
F
l
u
o
r
e
s
c
e
n
c
e
%
 
(
1
%
 
(
1
M
)
 
5
-
H
T
 
C
a
i
+
+
 
R
e
l
e
a
s
e
0
20
40
60
80
100
120
M100907, EC50 = 5.2 nM
SB242084, EC50 = 2.3 nM 
A 
[5HT] (log M)
 Veh  -10  -9  -8  -7  -6  -5  -4
R
e
l
a
t
i
v
e
 
F
l
u
o
r
e
s
c
e
n
c
e
%
B
a
s
e
l
i
n
e
100
150
200
250
300
5-HT, EC50 =  1.7 nM
+ 1 M SB216641
EC50 = 2.3 nM 
[5HT] (log M)
 Veh -10  -9  -8  -7  -6  -5  -4
R
e
l
a
t
i
v
e
 
F
l
u
o
r
e
s
c
e
n
c
e
%
B
a
s
e
l
i
n
e
100
102
104
106
108
110
B 
Figure 4 Effect of specific antagonists on Cai
++ release.C e l l s
were plated at 16,000 cells/well for 24 hrs, and loaded with Calcium
4 dye reagent. A. 5-HT2AR- or 5-HT2CR-CHO cells were preincubated
with M100907 or SB242084, respectively, for 15 min then stimulated
with 1 μM 5-HT. B. 5-HT2CR-CHO cells were preincubated with
vehicle or 1 μM SB216641 for 15 min then stimulated with varying
concentrations of 5-HT. Inset. Parental CHO-K1 cells (no
preincubation) were treated with varying concentrations of 5-HT. n
= 3-4 per group.
Table 1 EC50values for agonist-stimulated Cai
++ release
5-HT2AR 5-HT2CR
Serum-
starved
Serum-
replete
Serum-
starved
Serum-
replete
5-HT 0.8 nM 53 nM 0.7 nM 4.9 nM
DOI 3.6 nM > 24 μM 5.4 nM > 100 μM
MK212 No response No response > 280 nm > 11 μM
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Figure 5 Time course of ERK activation in 5-HT2AR- and 5-
HT2CR-CHO cells. Cells were plated at 16,000 cells/well for 24 hrs,
preincubated in serum-free medium overnight and stimulated with
vehicle (PBS) or 1 μM 5-HT for the indicated times. Levels of pERK
were determined by plate immunoassay and net values were
determined by subtraction of the vehicle control value from the 1
μM 5-HT value at each time point. Graph is representative of three
independent experiments, n = 5-6/experiment; * p < 0.05, ** p <
0.01 vs. t = 0 min.
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Page 8 of 14CHO cells at 10 min is also a typical oscillating pattern
[36,37,44-46]. A less dramatic and more variable drop
was observed at 10 min for the 5-HT2AR-CHO cells,
not reaching baseline until 20 min. A separate experi-
ment examined more closely spaced time points and
confirmed that there was no significant difference in
responses in either 5-HT2AR-or 5-HT2CR-expressing
CHO cells between 5 and 8 min (data not shown).
Cell density
To determine whether cell density affects ERK phos-
phorylation of 5-HT2Rs expressed in CHO cells, we pla-
ted 5-HT2CR-CHO cells at densities between 2,000 and
64,000 cells/well and stimulated with varying doses of 5-
HT for 5 min (Figure 6). Low cell numbers (< 8000
cells/well) yielded blunted 5-HT stimulations of pERK
(on a per cell basis) over vehicle control, possibly for
the same reasons as discussed for the Cai
++ assay
(above). Higher plating densities resulted in easily
detectable levels of ERK activation that did not differ
between 16,000 and 64,000 cells/well. Results for 5-
HT2AR-CHO cells were similar (data not shown).
Therefore, we adopted 16,000-32,000 cells/well as our
standard cell plating density condition for ERK studies,
as we did above for the Cai
++ assays.
Dose response to agonists
We examined the activation of ERK by varying concen-
trations of the two ligands: 5-HT and DOI. Results (nor-
malized to cell number) for 5-HT2AR-CHO cells are
s h o w ni nF i g u r e7 A ,Ba n df o r5 - H T 2CR-CHO cells in
7C, D. In both cell types, 5-HT and DOI caused concen-
tration-dependent increases in pERK, with maximal
responses at approximately 0.1 μMf o r5 - H Ta n d1μM
for DOI. EC50 values were: 12 nM (5-HT) and 31 nM
(DOI) for 5-HT2AR; 14 nM (5-HT) and 19 nM (DOI)
for 5-HT2CR. The magnitudes of the pERK responses to
both DOI and 5-HT were similar in both 5-HT2AR- and
5-HT2CR-CHO cells.
Effect of serum starvation
We also compared the activation of ERK following over-
night incubation in serum-replete (Figure 7, closed cir-
cles) versus serum-free (Figure 7, open circles)
conditions (as described above for the Cai
++ assays).
Serum-replete preincubation clearly suppressed the
response to both 5-HT and DOI in both 5-HT2AR- and
5-HT2CR-CHO cells.
Discussion
Studies of cell signaling outcomes are complex, and the
most-used techniques involve multiple and often differ-
ent manipulations of the cells to achieve quantitative
endpoints. The assays described here are minimally dis-
ruptive and offer improvements in speed, sensitivity,
quantification and flexibility in assay design compared
to traditional methods. For example, measurements of
Cai
++ release determined by fluorescent microscopy are
time-consuming and yield data on either a small num-
ber of cells [45,47] or suspensions of potentially
damaged cells. The No-Wash Cai
++ protocol avoids
multiple dye-removal and rinsing steps. Immunoblots
are time consuming, and the protein extraction, gel elec-
trophoresis and transfer steps introduce multiple
sources of variability, making truly quantitative compari-
sons difficult or impossible. The assays described herein
avoid these sources of error and provide easily quantifi-
able results while providing in situ information about
concurrent signaling events.
Temporal response patterns
For both 5-HT2AR and 5-HT2CR, the peak Cai
++ response
occurred 10 to 20 sec following stimulation, while activa-
tion of ERK was maximal at 5-8 min. These times agree
with previously published data using similar methods [28]
for these stably-transfected cells, and are consistent with
sequential events in signaling pathways [48].
Cell density
Higher numbers of cells provide greater membrane sur-
face area, but different cell types and their receptors
react differently to contact inhibition and/or the buildup
of secreted cellular “factors” in the growth medium,
sometimes resulting in decreased numbers of receptors/
cell at higher cell densities [40,49]. For 5-HT2AR- or 5-
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Page 9 of 14HT2CR-CHO cells, cell density was not critical for either
of the endpoints measured over a wide range, suggesting
that contact inhibition of responses via these 5-HT
receptors in CHO cells does not occur until the cells
are extremely dense (> 64,000 cells/well). Differences in
density-dependence likely hinge upon the individual
receptor under study, the receptor family to which it
belongs, the tissue of origin and the normal expression
density. Also, receptors that are expressed naturally in a
particular cell type may be subject to different control
mechanisms than receptors that have been expressed in
a heterologous cell type via transfection.
Agonist concentration
The ligand concentration required to achieve maximal
response varied between the two signaling measures. EC50
values for Cai
++ stimulation were 1-3 nM while those for
ERK activation were somewhat higher (Table 1 and Figure
7). This may suggest separate “wiring” for these two
modes of signaling, or the contribution of Cai
++ release to
an ERK response that also requires the participation of
other positive and/or negative signaling pathway compo-
nents that were not the subject of our studies. While direct
comparison of literature values of functional assays using
different cell lines, different receptor expression levels, dif-
ferently-edited isoforms (in the case of 5-HT2CR), and dif-
fering detection protocols is complex at best [50,51], the
EC50 values for 5-HT- and DOI-induced Cai
++ stimulation
that we obtained are consistent with values obtained in
similarly transfected 5-HT2AR- and 5-HT2CR-CHO cells
[38] and in the same line of 5-HT2CR-CHO cells [28]
using similar detection systems.
Effect of serum starvation
Many cell surface receptors are down-regulated in the
presence of serum [40]; overnight serum starvation is
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Page 10 of 14frequently used to minimize this effect. There was a
notable difference in growth medium requirements
between 5-HT2AR- and 5-HT2CR-expressing CHO cells
with regard to the Cai
++ response. In both, serum-free
preincubation caused a leftward shift in the concentra-
tion response curves to 5-HT. Incubation of 5-HT2CR-
CHO cells in serum-replete medium completely elimi-
nated the response to DOI and markedly decreased the
magnitude of the Cai
++ response to 5-HT, while in 5-
HT2AR-CHO cells, response magnitude was more vari-
able. In 5-HT2AR-CHO cells, the level of response fol-
lowing the absence of serum during the two-hour dye
incubation (Figure 2) suggests that two hours was suffi-
cient to achieve Cai
++ response levels similar to those
seen with overnight serum starvation. Therefore, 5-
HT2AR-CHO cells appear to be less affected by factors
in serum than do 5-HT2CR-CHO cells, though serum
inhibited the response to 5-HT- and DOI-induced sti-
mulation of ERK activation in both cell types. A more
proximal receptor-triggered event like Cai
++ release may
be more directly and differentially sensitive to serum-
resident ligands like 5-HT. Serum can contain appreci-
able and variable levels of 5-HT and continuous expo-
sure can result in desensitization [50]. In the case of the
5-HT2CR-CHO cells, the relatively high constitutive
activity of the INI isoform may have resulted in a simi-
lar “ceiling effect”, as could high levels of glutamate in
the medium with serum-stimulated glutamate receptors
leading to maximal influx of extracellular Ca
++ [52,53].
Exposure to such serum factors could result in
responses with different temporal profiles for the two
receptors, as ERK activation occurs as a result of many
inputs and lengthy signal cascades, which may muffle
the contributing effects of a single immediate response
in the composite [36,37,44,45].
Other signaling pathways
Although the best described pathway for 5-HT2R stimu-
lation of ERK activation may be G protein and PLC-
mediated Cai
++ release, it is not the only route that has
been documented. Distinct ligands for the same receptor
can activate different pathways preferentially [11,36,37].
Differential coupling to PLCb-mediated IP3 accumula-
tion or to PLA2-mediated AA release has been particu-
larly well studied in these 5-HT2AR-CHO cells [11,54].
The predominant choice or mixture of signaling
mechanisms can also depend on receptor numbers and
reserve [55][34], receptor conformation and occupancy
[56] and prior exposure to agonists [50] or inverse ago-
nists [12].
Other pathways have also been linked to ERK activa-
tion following ligand stimulation of 5-HT2R. In a variety
of cell types, binding of calmodulin to the C-terminus of
the 5-HT2CR recruits b-arrestin causes G protein-
independent ERK stimulation [35,57-60]. Ligand stimu-
lation of the 5-HT2AR can initiate a transactivation
pathway by which epidermal growth factor (EGF) binds
to its receptor (EGFR), resulting in ERK phosphorylation
[20,27,61,62]. Stimulation of ERK that is partially inde-
pendent of L-type Ca
++ channels and PLC has been
described in arterial smooth muscle [22,23]. Thus, there
are many different routes to ERK activation, and a more
complete picture may emerge as we accumulate infor-
mation in different cell types.
The presence of other receptors in these cells and the
presence or lack of various other cellular components
could also affect signaling cascades. In 5-HT2R-expres-
sing HEK cells [38,57] low levels of endogenous Gaq/11
[63] can complicate interpretation of results. Cross-talk
among the 5-HT2Rs themselves [12,55,64] and with
other families of co-expressed 5-HTRs [60][25,65] has
been described. Further study of diverse ligands with
alternative signaling endpoints should help to build the
complex picture of integrated signaling in cells expres-
sing this subset of 5-HT receptors.
RNA editing
Finally, signaling by 5-HT2CRs is also dependent on the
population of edited receptor isoforms expressed
[34,66], which affects their level of constitutive activity
[34,67-69]. The partially and fully edited isoforms also
demonstrate altered temporal and pharmacological char-
acteristics for ERK activation, including pathway selec-
tion [34]. Primary cultures of mouse cortical neurons
predominantly express constitutively active (less edited)
isoforms [63] while the 5-HT2CR-CHO cells used here
[11,14,39,64,70,71] and by Werry [28,34] were trans-
fected with the unedited human 5-HT2CR isoform; other
research has utilized partially-edited isoforms [38].
Therefore, differences between studies may be due to
differences between natively-expressing vs. transfected
cells and to the relative expression of edited and non-
edited forms.
Broader applications
The quantitative plate immunoassay is a particularly
versatile assay that can be adapted to precisely measure
a variety of important receptors and signaling protein
activations and is limited only by the availability of suffi-
ciently specific primary antibodies. With minor protocol
modifications the assay has been used to quantify other
cell surface receptors [40,42,72] the phosphorylation of
other MAPKs (Jnk and p38) [44,73] and the dopamine
transporter [74]. Relative intracellular vs. extracellular
localization of receptors and other proteins can be
detected by varying the fixation technique [49,72] and
we have begun exploring applications to ex vivo tissue
samples [75]. Differences in both Cai
++ and MAPK
Seitz et al. BMC Neuroscience 2012, 13:25
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Page 11 of 14signaling can be compared between many different cell
types and transfectants.
Conclusions
Serotonin- and 5-HT agonist-induced Cai
++ release and
ERK phosphorylation in 5-HT2AR- and 5-HT2CR-CHO
cells showed many signaling characteristics that were
similar, but with notable differences caused by growth
media. Components in serum blunted the Cai
++
response to 5-HT more dramatically in cells expressing
5-HT2CRt h a n5 - H T 2AR, and virtually eliminated the
Cai
++ response to DOI and pERK activation for both
receptors. These studies show that measuring changes
in Cai
++ and ERK activation in parallel is a useful
approach to dissecting intracellular responses to ligand
activation. These quantitative, sensitive, and adaptable
tools can be applied to a broad range of studies. The in
situ, multiwell platform accommodates comparative data
for multiple compounds within the same assay, which
should facilitate the assessment of new drugs.
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